ADVFN US – Market Content Editor

The proposed 24,000-square-foot hospital would give Influence Healthcare its first operating facility and represents an early execution milestone ahead of Auddia’s planned combination with Thramann Holdings to form McCarthy Finney. Key Investor Takeaways Why AUUD Stock Is in Focus Influence Healthcare has taken a significant step toward establishing its first operating hospital by signing an…

Rezolve Ai reaffirmed approximately $360 million of FY2026 revenue guidance after rapid first-half growth, while Google’s adoption of its distributed database technology provides a new reference point for its infrastructure-licensing strategy. Key Investor Takeaways Why RZLV Stock Is in Focus Rezolve Ai delivered a sharp acceleration in first-half revenue, reporting $130.8 million for the six…

The definitive acquisition would combine Kustom’s festival and ticketing operations with TFL’s profitable inventory distribution network and proprietary technology, subject to financing and other closing conditions. Key Investor Takeaways Why KUST Stock Is in Focus Kustom Entertainment has entered into a definitive Unit Purchase Agreement to acquire all outstanding equity interests in TFL, positioning the…

The six-year contracts add long-duration international demand for Elbit Systems’ SPECTRO and AMPS NG technologies as the company executes against a $32 billion order backlog. Key Investor Takeaways Why ESLT Stock Is in Focus Elbit Systems has secured approximately $270 million of contracts from an international customer covering advanced intelligence, surveillance, reconnaissance and targeting payloads.…

The completed acquisition adds PALSONIFY and atumelnant to Vertex’s portfolio, with the two therapies carrying combined peak annual revenue potential of more than $5 billion according to the company. Key Investor Takeaways Why VRTX Stock Is in Focus Vertex Pharmaceuticals has completed its acquisition of Crinetics Pharmaceuticals, closing a transaction valued at approximately $10 billion…

The proposed exclusive U.S. distribution agreement would give Kala a commercial opportunity in its established ophthalmology market while leaving Virotek responsible for laboratory operations and clinical reporting. Key Investor Takeaways Why KALA Stock Is in Focus Kala Bio has entered into a letter of intent with Virotek outlining a proposed exclusive U.S. distribution partnership for…

The multi-million-dollar contract brings AEye into the space mobility market, expanding Apollo lidar beyond automotive, defense and industrial applications into lunar navigation. Key Investor Takeaways Why LIDR Stock Is in Focus AEye has entered the space mobility market after Lunar Outpost selected its Apollo long-range lidar for integration into the Pegasus Lunar Terrain Vehicle. The…

The company is evaluating an additional application for CyPath Lung that could complement CT imaging when monitoring lung cancer survivors for recurrence or new primary cancers. Key Investor Takeaways Why BIAF Stock Is in Focus bioAffinity Technologies is advancing the potential use of CyPath Lung as a surveillance tool for patients who have completed curative-intent…

The proposed 70% Tekne acquisition is now expected to close in the first half of October as NUBURU moves from assembling its Defense & Security platform toward integrating its operating capabilities. Key Investor Takeaways Why BURU Stock Is in Focus NUBURU has provided a more specific closing timetable for its proposed acquisition of a 70%…

The Orchestra development demonstration combines muscle-activity sensing with first-person vision to capture force-related information and maintain hand data when cameras lose visibility. Key Investor Takeaways Why WETO Stock Is in Focus Wetour Robotics has released a development demonstration of Orchestra, its Physical AI platform combining surface electromyography, or sEMG, with first-person vision to address two…